Hanna Ashraf 4
4 · Nexvet Biopharma plc · Filed Aug 2, 2017
Insider Transaction Report
Form 4
Hanna Ashraf
Director
Transactions
- Disposition to Issuer
Ordinary Shares
2017-07-31$6.72/sh−1,500$10,080→ 0 total(indirect: By Trust) - Disposition to Issuer
Ordinary Shares
2017-07-31$6.72/sh−16,020$107,654→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer.